VANGUARD GROUP INC - ONCOBIOLOGICS INC ownership

ONCOBIOLOGICS INC's ticker is ONS and the CUSIP is 68235M105. A total of 16 filers reported holding ONCOBIOLOGICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ONCOBIOLOGICS INC
ValueSharesWeighting
Q3 2018$561,000
+114.9%
572,805
+85.4%
0.00%
Q2 2018$261,000
-6.1%
309,037
-1.2%
0.00%
Q1 2018$278,000
-30.0%
312,707
+2.4%
0.00%
Q4 2017$397,000
-5.0%
305,2670.0%0.00%
Q3 2017$418,000
+46.7%
305,267
+8.0%
0.00%
Q2 2017$285,000
-62.4%
282,7400.0%0.00%
Q1 2017$757,000
-10.0%
282,740
+1.2%
0.00%
Q4 2016$841,000
+112.4%
279,273
+199.9%
0.00%
Q3 2016$396,00093,1150.00%
Other shareholders
ONCOBIOLOGICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,027,216$3,493,0000.50%
ACUTA CAPITAL PARTNERS, LLC 243,391$828,0000.40%
SABBY MANAGEMENT, LLC 2,068,968$7,035,0000.37%
Avoro Capital Advisors LLC 466,667$1,587,0000.35%
Perceptive Advisors 1,312,763$4,463,0000.31%
Monashee Investment Management LLC 50,000$170,0000.27%
SPHERA FUNDS MANAGEMENT LTD. 259,000$881,0000.23%
PointState Capital LP 200,000$680,0000.01%
MARSHALL WACE, LLP 250,200$851,0000.01%
Hudson Bay Capital Management LP 62,500$213,0000.01%
View complete list of ONCOBIOLOGICS INC shareholders